De Novo Truncating Mutations in WASF1 Cause Intellectual Disability with Seizures

Yoko Itō(University of Tsukuba), Helen Dolling, Matthew A. Brown(Translational Research Institute), Boris Keren(Sorbonne Université), David Bennett(University of Oxford), Taco W. Kuijpers(Sanquin), Carla Mendonça(Radboud University Nijmegen), Patrick F. Chinnery(Wellcome Centre for Mitochondrial Research), Hans van Bokhoven(Radboud University Nijmegen), John Davis, Willem H. Ouwehand(NHS Blood and Transplant), Adrian J. Thrasher(Great Ormond Street Hospital), Rolph Pfundt(Radboud University Nijmegen), Tracey Hammerton, Manju A. Kurian(Great Ormond Street Hospital), Tim Young(Auckland University of Technology), Anthony van Essen(Dalhousie University), Nicholas W. Morrell(University of Cambridge), Nathalie Kingston, Marijke Veltman, Hugh Watkins(John Radcliffe Hospital), Caroline Nava(Centre National de la Recherche Scientifique), Michael Laffan(Oxford University Hospitals NHS Trust), Timothy J. Aitman(Institute of Genetics and Cancer), Irene Roberts(Hammersmith Hospital), Catherine Williamson(Imperial College London), Roger James, Kathleen Stirrups(Queen Mary University of London), Eamonn R. Maher(Aston University), Hugh S. Markus(University of Cambridge), Eleanor Dewhurst, Daniel P. Gale(Renal Association), Taila Hartley(University of Ottawa), Debra Fletcher, Sofia Duarte(University of Ottawa), John R. Bradley(University of Cambridge), Sofie Ashford(University of Cambridge), Christopher J. Penkett(University of Cambridge), Mark J. Caulfield(Queen Mary University of London), Ania Koziell, Alba Sanchis‐Juan(University Medical Center Groningen), Emma Clement, F. Lucy Raymond(University of Cambridge), Conny M.A. van Ravenswaaij‐Arts(University Medical Center Groningen), Geoffrey Woods, Isabelle Marey(Assistance Publique – Hôpitaux de Paris), David J. Perry(National Health Service), Kenneth G. C. Smith(The University of Melbourne), Perinne Charles(Sorbonne Université), Keren Carss(AstraZeneca (United Kingdom))
The American Journal of Human Genetics
June 28, 2018
10.1016/j.ajhg.2018.06.001
Cited by 48

Related Papers

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial
|The Lancet|2003|3.8k
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial
|The Lancet|2005|2.9k
Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
|The Lancet|2014|1.6k
Mitochondrial diseases
|Nature Reviews Disease Primers|2016|1.5k
Mutations in Fas Associated with Human Lymphoproliferative Syndrome and Autoimmunity
|Science|1995|1.3k